NCT05656482

Ability of a Cat Food to Reduce Respiratory Symptoms in Cat Allergic Patients

Evaluation of the Ability of a Cat Food to Reduce Respiratory Symptoms in Cat Allergic Patients: Pilot Study

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 50 (estimated)
• Sponsor: MASK-air SAS · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: —

Summary

Cat allergy is the most common animal allergy, affecting approximately 1 in 5 adults worldwide. The prevalence of allergy to furry animals is increasing, and cat allergy is a major risk factor for the development of asthma and rhinitis. Fel-d1 is the major feline allergen, to which 95% of cat allergic people react. All cats produce Fel-d1 regardless of breed, age, coat type, sex or weight. Fel-d1 is contained primarily in the saliva and sebum of cats. This allergy manifests itself as allergic rhinitis (AR) (sneezing, cold, coughing, conjunctivitis with watering and itching), severe asthma, and irritation and swelling of the skin when scratched. A new approach to managing cat allergies is to neutralize the allergens at the source by feeding domestic cats a diet containing anti-Fel-d1 IgY antibodies. The purpose of this pilot study is to determine whether feeding domestic cats a food containing an egg product with anti-Fel d1 IgY (PRO PLAN® LIVECLEAT®) induces a reduction of allergic symptoms in their owners.

Conditions

• Rhinitis, Allergic

Interventions

Type	Name	Description
OTHER	Cats fed with PRO PLAN® LIVECLEAT®	Patient with domestic cats fed with an egg product containing anti-Fel d1 IgY (PRO PLAN® LIVECLEAT®)

Timeline

• Start date: 2022-05-06
• Primary completion: 2023-04-05
• Completion: 2023-04-15
• First posted: 2022-12-19
• Last updated: 2023-03-07

Locations

1 site across 1 country: France